Cavernous angioma surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 19: | Line 19: | ||
**[[Calcification]] | **[[Calcification]] | ||
**[[Hyaline degeneration]] <ref name="pmid12826334">{{cite journal| author=Wang CC, Liu A, Zhang JT, Sun B, Zhao YL| title=Surgical management of brain-stem cavernous malformations: report of 137 cases. | journal=Surg Neurol | year= 2003 | volume= 59 | issue= 6 | pages= 444-54; discussion 454 | pmid=12826334 | doi=10.1016/s0090-3019(03)00187-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12826334 }} </ref> | **[[Hyaline degeneration]] <ref name="pmid12826334">{{cite journal| author=Wang CC, Liu A, Zhang JT, Sun B, Zhao YL| title=Surgical management of brain-stem cavernous malformations: report of 137 cases. | journal=Surg Neurol | year= 2003 | volume= 59 | issue= 6 | pages= 444-54; discussion 454 | pmid=12826334 | doi=10.1016/s0090-3019(03)00187-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12826334 }} </ref> | ||
*If [[seizure surgery]] occurs, [[hemosiderin ring]] should be removed.<ref name="pmid18754072">{{cite journal| author=Cenzato M, Stefini R, Ambrosi C, Giovanelli M| title=Post-operative remnants of brainstem cavernomas: incidence, risk factors and management. | journal=Acta Neurochir (Wien) | year= 2008 | volume= 150 | issue= 9 | pages= 879-86; discussion 887 | pmid=18754072 | doi=10.1007/s00701-008-0008-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18754072 }} </ref> | *If [[seizure surgery]] occurs, the [[hemosiderin ring]] should be removed.<ref name="pmid18754072">{{cite journal| author=Cenzato M, Stefini R, Ambrosi C, Giovanelli M| title=Post-operative remnants of brainstem cavernomas: incidence, risk factors and management. | journal=Acta Neurochir (Wien) | year= 2008 | volume= 150 | issue= 9 | pages= 879-86; discussion 887 | pmid=18754072 | doi=10.1007/s00701-008-0008-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18754072 }} </ref> | ||
* | * | ||
| Line 28: | Line 28: | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category: | [[Category:Up to Date]] | ||
Latest revision as of 13:07, 12 May 2022
|
Cavernous angioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cavernous angioma surgery On the Web |
|
American Roentgen Ray Society Images of Cavernous angioma surgery |
|
Risk calculators and risk factors for Cavernous angioma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Surgery is the mainstay treatment for cavernous angioma. Complete surgical resection should be done to prevent seizures and hemorrhage due to remnant tissue.
Indication
Surgery
- Surgical resection is the most preferred intervention for cavernous angioma.
- Complete resection is needed as remnant tissue can cause high risk of seizure and hemorrhage.[1]
- Factors that complicate procedure include:
- Presence of gliosis
- Calcification
- Hyaline degeneration [2]
- If seizure surgery occurs, the hemosiderin ring should be removed.[3]
References
- ↑ Stapleton CJ, Barker FG (2018). "Cranial Cavernous Malformations: Natural History and Treatment". Stroke. 49 (4): 1029–1035. doi:10.1161/STROKEAHA.117.017074. PMID 29535273.
- ↑ Wang CC, Liu A, Zhang JT, Sun B, Zhao YL (2003). "Surgical management of brain-stem cavernous malformations: report of 137 cases". Surg Neurol. 59 (6): 444–54, discussion 454. doi:10.1016/s0090-3019(03)00187-3. PMID 12826334.
- ↑ Cenzato M, Stefini R, Ambrosi C, Giovanelli M (2008). "Post-operative remnants of brainstem cavernomas: incidence, risk factors and management". Acta Neurochir (Wien). 150 (9): 879–86, discussion 887. doi:10.1007/s00701-008-0008-4. PMID 18754072.